RxDoctor Payments Data

Joshua Hall

Addiction Medicine · Spartanburg, SCNPI 1497135503

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 29.4% of the total. Reporting peaked in 2023 at $1,223 and has fallen 79.4% since, to $252 in 2025.

$2,607in general payments, 2019–2025

Across 129 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$766
  • Indivior Inc.$429
  • Alkermes, Inc.$424
  • AstraZeneca$240
  • Braeburn Inc.$130
  • Abbott$94
  • plus $524 from 17 others

What the payments were for

  • Food & beverage$2,57299%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few addiction medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VivitrolNaltrexone Microspheres29$48,335
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl231$32,264
Gabapentin48$1,162
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$1,067
Clonazepam83$547
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine15$489
Ondansetron Hcl28$318
Diazepam27$151
Alprazolam12$124
Trazodone Hcl14$54

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Vivitrol$424$48,33529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few addiction medicine providers in South Carolinaon file to place this against a meaningful peer group, so we don't.

Other addiction medicine in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →